Distribution Services · Wholesale Distributors · NSE: SAROJA · data 2026-10-09
Saroja Pharma Industries India Ltd.
Health check: Strong (7/10 on quality, valuation vs sector, growth and momentum).
Open full analysis — chart, results, balance sheet, red flags →Key figures
Price
₹40.8
Market cap
₹16 cr
P/E
10.2
P/B
1
ROE
9.8%
ROCE
17.9%
Debt / equity
0.83
Dividend yield
0.00%
1-year return
-12.8%
52-week high
₹48
52-week low
₹28
Operating margin
5.7%
Growth
| Revenue (last 12 months) | ₹71 cr |
| Net profit (last 12 months) | ₹2 cr |
| Sales growth, 3 years (yearly) | 11.8% |
| Profit growth, 3 years (yearly) | 15.0% |
Similar companies
QVC Exports Limited (QVCEL) · Aspire & Innovative Advertising Limited (ASPIRE) · Sri Havisha Hospitality And Infrastructure Ltd (HAVISHA) · Agarwal Float Glass India Limited (AGARWALFT) · Shrenik Limited (SHRENIK)
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open SAROJA in NSE Scanner →